These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17848422)

  • 1. Evaluation of centrally acting cholinesterase inhibitor exposures in adults.
    McCain KR; Sawyer TS; Spiller HA
    Ann Pharmacother; 2007 Oct; 41(10):1632-7. PubMed ID: 17848422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors in the treatment of dementia.
    Ellis JM
    J Am Osteopath Assoc; 2005 Mar; 105(3):145-58. PubMed ID: 15863734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poisoning in older adults: a 5-year experience of US poison control centers.
    Crouch BI; Caravati EM; Mitchell A; Martin AC
    Ann Pharmacother; 2004 Dec; 38(12):2005-11. PubMed ID: 15522976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinesterase duration in the Australian veteran population.
    Gadzhanova S; Roughead L; Mackson J
    Aust N Z J Psychiatry; 2010 May; 44(5):469-74. PubMed ID: 20397790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.
    Lockhart IA; Mitchell SA; Kelly S
    Dement Geriatr Cogn Disord; 2009; 28(5):389-403. PubMed ID: 19893314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
    Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective review of California poison control system data of sibutramine exposures.
    Minns AB; Ebrahimi S; Te L; Ly B; Clark RF; Cantrell FL
    Clin Toxicol (Phila); 2009 Sep; 47(8):814-7. PubMed ID: 19778191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective poison center review of varenicline-exposed patients.
    Kreshak AA; Clark AK; Clark RF; Ly BT; Cantrell FL
    Ann Pharmacother; 2009 Dec; 43(12):1986-91. PubMed ID: 19934384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic effects from metformin exposure.
    Spiller HA; Quadrani DA
    Ann Pharmacother; 2004 May; 38(5):776-80. PubMed ID: 15031415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Pediatric Exposures to Antidementia Drugs Reported to a Poison Control System.
    Thornton SL; Pchelnikova JL; Cantrell FL
    J Pediatr; 2016 May; 172():147-50. PubMed ID: 26935787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin exposures reported to Texas poison centers in 1998-2003.
    Forrester MB
    Vet Hum Toxicol; 2004 Dec; 46(6):345-6. PubMed ID: 15587262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of Alzheimer's disease: past, present, and future.
    Ott BR
    Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092
    [No Abstract]   [Full Text] [Related]  

  • 17. Tramadol exposures reported to statewide poison control system.
    Marquardt KA; Alsop JA; Albertson TE
    Ann Pharmacother; 2005 Jun; 39(6):1039-44. PubMed ID: 15870139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.
    Kröger E; Berkers M; Carmichael PH; Souverein P; van Marum R; Egberts T
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):373-80. PubMed ID: 23217530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
    Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
    J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.